Goldman Sachs lifts Netflix (Nasdaq: NFLX) from Neutral to Buy and adjusts its price target from $380 up to $590. Click Here for more color.
Amicus Therapeutics (Nasdaq: FOLD) upgraded by two today:
- Leerink Swann from Market Perform to Outperform; and
- Janney Montgomery Scott from Neutral to Buy and moves its price target from $2.50 up to $5.
Wolfe Research upgrades YRC Worldwide (Nasdaq: YRCW) from Underperform to Peerperform.
Raymond James moves Nabors (NYSE: NBR) from Market Perform to Outperform with a price target of $35.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES
Bernstein drops Goldman Sachs